News | February 20, 2018

Iterum Announces the appointment of Jeff Schaffnit as Chief Commercial Officer Industry Veteran To Lead Commercialization of Potential New Oral and IV Antibiotic DUBLIN and CHICAGO, Feb. 20, 2018 /PRNewswire/ — Iterum Therapeutics Limited, a clinical-stage...